PIK3CA in HER2+ BC and pCR Trial

Clinical trial NCT05750693 · UNKNOWN

Trial details

NCT number: NCT05750693
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2022-05-02
Primary completion: 2023-09-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.